Jump to content

Baupost Group Builds 28% Stake In Drug-Maker


indythinker85
 Share

Recommended Posts

These are all outside my circle of competence and I would speculate are for most of us.  But you gotta remember one of the unique things about Baupost vs other very successful value investors is that he has a huge staff.  180+ employees as of the last article I've seen about it.  So they have a deeper pool of specialists than most of the funds we typically look at.  Being in Boston also probably has its advantages.  There is a huge biotech industry, bunch of very good medical schools, plus nearly every I-Bank / Consulting group's top healthcare people are based in Boston.  Id wager they have a few very smart MDs working there.

Link to comment
Share on other sites

I looked at it when the most recent FDA hold was placed, but didn't open a position.  To me, the investment in THRX is much easier to wrap your brain around.  I mean you have a recent valuation on the license revenue stream from the elan bid.  I made some decent cake in Chiron in a similar situation years ago (with a major pharma holding a controlling/large interest in a smaller biopharma) so I may be feeling nostalgic.

Link to comment
Share on other sites

I looked at IDIX and other drug pharms for a while but could not understand anything, even though I have a degree in biology. :(

 

LOL such a good quote. Its outside my circle but was just curious, I dont plan to buy the company. Interesting earlier post about Boston and medicine i was thinking along those lines. I did not realize Baupost has 180 employees thought it was closer to 100.

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
 Share

×
×
  • Create New...